D active O KING,MATTHEW MICHAEL 3110624.190941 1 PENICILLIN 4019880 3110624.1909 050 VOE OFFICE INSTITUTION 57 2505;PS(50.416, ALLERGY PENICILLIN HIVES MODERATE O 4019880 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 26 CH;6889372.84;3 336 BUN 14937-7 6 809 18 3110626.190006 SERUM 0X500 SERUM completed BUN CH mg/dL 4656523 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 1.4 CH;6889372.84;4 336 CREAT 14682-9 .9 808 1.0 3110626.190006 SERUM 0X500 SERUM completed CREATININE CH mg/dL 4656243 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 145 CH;6889372.84;5 336 NA 2951-2 135 810 141 3110626.190006 SERUM 0X500 SERUM completed SODIUM CH meq/L 4671912 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 200 CH;6889372.84;12 336 CHOL 14647-2 120 806 162 3110626.190006 SERUM 0X500 SERUM completed CHOLESTEROL CH mg/dL 4656205 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 150 CH;6889372.84;47 H 336 TRIGLYC 14927-8 36 805 177 3110626.190006 SERUM 0X500 SERUM completed TRIGLYCERIDE CH mg/dL 4656512 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 CH;6889372.84;80 336 HDL 14646-4 804 43 3110626.190006 SERUM 0X500 SERUM completed HDL CH MG/DL 4656204 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 CH;6889372.84;291 336 LDL CHO 2089-1 803 84 3110626.190006 SERUM 0X500 SERUM completed LDL CHOLESTEROL CH MG/DL 4662734 3110626.16 preserve Report Released Date/Time: Jun 26, 2011@19:00 100 VOE OFFICE INSTITUTION CH 0626 47 101 CH;6889372.84;67003 H 336 FBLDGLU 14771-0 69 807 178 3110626.190006 SERUM 0X500 SERUM completed FASTING BLOOD GLUCOSE CH MG/DL 4656342 0 by mouth DAILY 050 VOE OFFICE INSTITUTION TAB 1N;O GLYBURIDE TAB 3110624.191511 63 KING,MATTHEW MICHAEL ORAL HYPOGLYCEMIC AGENTS,ORAL 400 GLYBURIDE 4018078 2877 GLYBURIDE 2.5MG TAB 4003456 235 GLYBURIDE 2.5MG U/D D preserve Glyburide 2.5 mg Tab| 1 tablet BY by mouth DAILY 3110624.1818 active OTC N 0 by mouth BID mg Tab| 1 tablet 050 VOE OFFICE INSTITUTION TAB 2N;O FUROSEMIDE TAB 3110624.191511 63 KING,MATTHEW MICHAEL LOOP DIURETICS 197 FUROSEMIDE 4017830 1784 FUROSEMIDE 20MG TAB 4002369 228 FUROSEMIDE 20MG U/D D preserve Lasix 20 mg Tab| 1 tablet BY by mouth BID 3110624.182 active OTC N 0 by mouth DAILY mg Tab| 1 tablet 050 VOE OFFICE INSTITUTION TAB 3N;O ATORVASTATIN TAB 3110624.191511 63 KING,MATTHEW MICHAEL ANTILIPEMIC AGENTS 3382 ATORVASTATIN 4024041 12595 ATORVASTATIN CA 10MG TAB 4012960 94208 ATORVASTATIN 10MG D preserve Lipitor 10 mg Tab| 1 tablet BY by mouth DAILY 3110624.1819 active OTC N 0 by mouth BID 1 050 VOE OFFICE INSTITUTION TAB,SA 4N;O POTASSIUM CHLORIDE TAB,SA 3110624.191511 63 KING,MATTHEW MICHAEL POTASSIUM 19 POTASSIUM CHLORIDE 4017447 234 POTASSIUM CHLORIDE 10MEQ TAB,SA 4000856 5233 POTASSIUM CHLORIDE 10MEQ TAB D preserve Klor-Con 10 10 mEq Tab| 1 tablet BY by mouth BID 3110624.1822 active OTC N TULSA 74108 OKLAHOMA 12 E.36th St H2653P 2530126 AO 050 VOE OFFICE INSTITUTION HARRIS HARRIS,JOHN M JOHN 32 36 0 403012653P 0 C 3110505 100 VOE OFFICE INSTITUTION OLD 250.02 57 Diabetes Mellitus without mention of Complication, type II or unspecified type, 3030405 76 VAN NESS,NANCY 0 0 A 0 3110624 C 3110505 100 VOE OFFICE INSTITUTION OLD 401.9 58 Essential Hypertension 3070506 76 VAN NESS,NANCY 0 0 A 0 3110624 C 3110624 100 VOE OFFICE INSTITUTION 414.01 172 DR OFFICE Coronary Atherosclerosis of Native Coronary Vessel 3020504 63 KING,MATTHEW MICHAEL 0 0 A 0 3110624 C 3110624 100 VOE OFFICE INSTITUTION 272.4 173 DR OFFICE Other and unspecified hyperlipidemia 3050405 63 KING,MATTHEW MICHAEL 0 0 A 0 3110624